These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1446 related items for PubMed ID: 9075719

  • 1. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB, Fairhall KM, Robinson IC.
    Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
    [Abstract] [Full Text] [Related]

  • 2. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E, Maccagno B, Ramunni J, Di Vito L, Broglio F, Deghenghi R, Camanni F, Ghigo E.
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat.
    Clark RG, Thomas GB, Mortensen DL, Won WB, Ma YH, Tomlinson EE, Fairhall KM, Robinson IC.
    Endocrinology; 1997 Oct; 138(10):4316-23. PubMed ID: 9322945
    [Abstract] [Full Text] [Related]

  • 4. ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF.
    Hirotani C, Oki Y, Ukai K, Okuno T, Kurasaki S, Ohyama T, Doi N, Sasaki K, Ase K.
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):54-60. PubMed ID: 15645295
    [Abstract] [Full Text] [Related]

  • 5. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin.
    Kent P, Anisman H, Merali Z.
    Neuroendocrinology; 2001 Mar; 73(3):203-14. PubMed ID: 11307039
    [Abstract] [Full Text] [Related]

  • 6. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin.
    Morimoto I, Yamamoto S, Kai K, Fujihira T, Morita E, Eto S.
    Neuroendocrinology; 2000 Jun; 71(6):366-74. PubMed ID: 10878498
    [Abstract] [Full Text] [Related]

  • 7. The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
    Korbonits M, Kaltsas G, Perry LA, Putignano P, Grossman AB, Besser GM, Trainer PJ.
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2489-95. PubMed ID: 10404825
    [Abstract] [Full Text] [Related]

  • 8. Responses induced by arginine-vasopressin injection in the plasma concentrations of adrenocorticotropic hormone, cortisol, growth hormone and metabolites around weaning time in goats.
    Katoh K, Yoshida M, Kobayashi Y, Onodera M, Kogusa K, Obara Y.
    J Endocrinol; 2005 Nov; 187(2):249-56. PubMed ID: 16293772
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M, Cover PO, Poyser RH, Buckingham JC.
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [Abstract] [Full Text] [Related]

  • 10. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM, Vaughan JM, Donaldson CJ, Rivier J, Li C, Chen A, Vale WW.
    Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
    [Abstract] [Full Text] [Related]

  • 11. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
    Rigamonti AE, Bonomo SM, Cella SG, Müller EE.
    J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
    [Abstract] [Full Text] [Related]

  • 12. Effects of fetal ethanol exposure on pituitary-adrenal sensitivity to secretagogues.
    Osborn JA, Yu C, Stelzl GE, Weinberg J.
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1110-9. PubMed ID: 10924017
    [Abstract] [Full Text] [Related]

  • 13. The hypothalamic melanocortin system stimulates the hypothalamo-pituitary-adrenal axis in vitro and in vivo in male rats.
    Dhillo WS, Small CJ, Seal LJ, Kim MS, Stanley SA, Murphy KG, Ghatei MA, Bloom SR.
    Neuroendocrinology; 2002 Apr; 75(4):209-16. PubMed ID: 11979051
    [Abstract] [Full Text] [Related]

  • 14. Control of the hypothalamo-pituitary-adrenal axis in the neonatal period: adrenocorticotropin and corticosterone stress responses dissociate in vasopressin-deficient brattleboro rats.
    Zelena D, Domokos A, Barna I, Mergl Z, Haller J, Makara GB.
    Endocrinology; 2008 May; 149(5):2576-83. PubMed ID: 18276753
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
    Gil-Lozano M, Romaní-Pérez M, Outeiriño-Iglesias V, Vigo E, González-Matías LC, Brubaker PL, Mallo F.
    Endocrinology; 2014 Jul; 155(7):2511-23. PubMed ID: 24731096
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.